• $232.5M
    Market Cap
  • 43.92%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
-267,000
-140.09%
666,000
-3.06%
687,000
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-267,000
-140.09%
666,000
-3.06%
687,000
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-90.4M
-6.53%
-96.7M
-0.03%
-96.8M
+6.46%
-90.9M
+43.34%
Depreciation and Amortization Expense
9.2M
+0.45%
9.2M
+55.94%
5.9M
+122.56%
2.6M
+50.17%
Total Operating Expenses
122.0M
-4.83%
128.2M
-2.63%
131.7M
+10.67%
119.0M
+37.63%
Operating Profit
-122.0M
-4.83%
-128.2M
-2.63%
-131.7M
+10.67%
-119.0M
+37.63%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
17.9M
-7.68%
19.4M
+37.14%
14.1M
+176.46%
5.1M
+1,345.76%
Income before Taxes
-122.0M
-4.83%
-128.2M
-2.63%
-131.7M
+10.67%
-119.0M
+37.63%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-104.1M
-4.33%
-108.8M
-7.41%
-117.5M
+3.22%
-113.8M
+32.25%
Net Income from Continuing Operations Applicable to Common
-104.1M
-4.33%
-108.8M
-7.41%
-117.5M
+3.22%
-113.8M
+32.25%
Basic EPS and Net Income
-1.41
-11.87%
-1.60
-33.33%
-2.40
-8.05%
-2.61
-0.38%
Diluted EPS and Net Income
-1.41
-11.87%
-1.60
-33.33%
-2.40
-8.05%
-2.61
-0.38%
Basic Weighted Average Shares
74.0M
+9.03%
67.9M
+38.46%
49.0M
+12.34%
43.6M
+32.79%
Diluted Weighted Average Shares
74.0M
+9.03%
67.9M
+38.46%
49.0M
+12.34%
43.6M
+32.79%
Balance Sheet
Cash and Cash Equivalents
39.6M
+42.19%
27.9M
-10.20%
31.0M
-17.21%
37.5M
-38.35%
Short-Term Investments
236.6M
-1.18%
239.5M
+10.28%
217.1M
-30.99%
314.6M
+77.50%
Cash and Cash Equivalents and Short-Term Investments
276.3M
+3.34%
267.4M
+7.72%
248.2M
-29.52%
352.1M
+47.90%
Total Current Assets
282.5M
+3.36%
273.3M
+8.01%
253.1M
-29.84%
360.7M
+46.75%
Accumulated Depreciation
29.0M
+38.89%
20.8M
+78.27%
11.7M
+100.77%
5.8M
+82.74%
Property and Plant and Equipment and Net
66.7M
-10.63%
74.7M
-5.88%
79.3M
+28.14%
61.9M
+381.55%
Total Long-Term Assets
1.7M
-58.18%
4.1M
+6.90%
3.8M
+105.19%
1.9M
+24.08%
Total Assets
404.2M
-19.35%
501.2M
+32.28%
378.9M
-19.89%
472.9M
+72.67%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
2.7M
N/A
N/A
N/A
Total Current Liabilities
22.3M
+17.70%
18.9M
-18.92%
23.3M
+5.82%
22.0M
+70.33%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
87,000
0.00%
87,000
-99.89%
82.3M
+456,955.56%
18,000
0.00%
Total Liabilities
91.9M
-1.44%
93.2M
-11.72%
105.6M
+4.83%
100.7M
+339.18%
Retained Earnings
-648.3M
+19.13%
-544.2M
+24.98%
-435.4M
+36.96%
-317.9M
+55.78%
Total Stockholders Equity
312.3M
-23.45%
408.0M
+49.29%
273.3M
-26.58%
372.2M
+48.31%
Total Shares Outstanding
71.1M
+0.61%
70.6M
+43.64%
49.2M
+0.62%
48.9M
+48.24%
Cash Flow
Cash from Operating Activities
-88.7M
-11.03%
-99.7M
+15.71%
-86.2M
+51.16%
-57.0M
-16.09%
Capital Expenditures
1.2M
-72.60%
4.4M
-84.34%
28.1M
-40.25%
47.1M
+837.53%
Cash from Investing Activities
100.3M
+177.43%
-129.6M
-263.96%
79.0M
+142.78%
-184.7M
-667.68%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
141,000
-99.94%
226.1M
+32,618.38%
691,000
-99.68%
219.0M
+18,120.63%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
45,691.76%
+337.38%
-19,248.35%
+0.45%
-19,163.03%
N/A
N/A
N/A
Return on Assets
-22.99%
-7.00%
-24.72%
-10.39%
-27.59%
-9.50%
-30.48%
+8.30%
Return on Equity
-28.90%
-9.51%
-31.94%
-12.27%
-36.41%
-0.35%
-36.53%
+21.43%
Revenue Growth
-140.09%
+4,482.90%
-3.06%
N/A
N/A
N/A
N/A
N/A
Current Ratio
12.69
-12.19%
14.45
+33.21%
10.85
-33.70%
16.36
-13.84%
Cash Ratio
1.78
+20.81%
1.47
+10.74%
1.33
-21.77%
1.70
-63.81%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow